(Q36892498)

16 August 2017

1 reference

title

The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular disease (English)

1 reference

16 August 2017

Eberhard Windler

1

1 reference

16 August 2017

Mark Schöffauer

series ordinal

2

1 reference

16 August 2017

Birgit-Christiane Zyriax

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

Diabetes and Vascular Disease Research

16 August 2017

published in

1 reference

16 August 2017

volume

4

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

136-142

1 reference

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Prevention of cardiovascular events in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

High-density lipoproteins: epidemiologic profile and risks of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

The emergence of the metabolic syndrome with menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Obesity as the core of the metabolic syndrome and the management of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Effects of a weight reduction program with and without aerobic exercise in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Cigarette smoking and HDL cholesterol the Framingham offspring study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

The forgotten majority: unfinished business in cardiovascular risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Prolonged-release nicotinic acid: a review of its use in the treatment of dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project).

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Beneficial effects of rosuvastatin alone and in combination with extended-release niacin in patients with a combined hyperlipidemia and low high-density lipoprotein cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.032

21 January 2018

Identifiers

DOI

10.3132/DVDR.2007.032

1 reference

16 August 2017

1 reference